Revaprazan Hydrochloride CAS 178307-42-1 Assay ≥99.0% API Factory Maʻemaʻe Kiʻekiʻe
Inoa Kemika: Revaprazan Hydrochloride;Revaprazan HCL
CAS: 178307-42-1
API no ke kūlana kiʻekiʻe, hana kālepa
Inoa Kimia | Revaprazan Hydrochloride |
Nā huaʻōlelo like | Revaprazan HCL |
Helu CAS | 178307-42-1 |
Helu CAT | RF-API48 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram |
ʻĀpana Molekala | C22H24ClFN4 |
Kaumaha Molecular | 398.904 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Keʻokeʻo a i ʻole ke keʻokeʻo Crystalline pauda |
Ka hikiwawe | Hiki ke hoʻoheheʻe ʻia i loko o ka chloroform, dichlormeth;Hiki ke hoʻoheheʻe ʻia i ka Acetic acid;Hiki ke hoʻoheheʻe ʻia i ka methanol, DMSO;ʻAʻole hiki ke hoʻoheheʻe ʻia i ka acetone, ACN;Aneane ʻaʻole hiki ke hoʻoheheʻe ʻia i ka hopena 0.1mol/L NaOH.0.1mol/L HCL hoʻonā. |
ʻIkepili | Pono e pane maikaʻi ʻia λ max 271nm, 205nm IR |
Lae hehee | 219.0~222.0 ℃ |
Ka malamalama a me ke kala | Pono e akaka a kala ole i ka dichlormeth |
Klorida | ≤8.93% |
Hoʻokahi haumia | ≤0.10% |
Huina paumaele | ≤0.50% |
Nalo ma ka maloo | ≤0.50% |
Koena ma ka Ignition | ≤0.10% |
Sulfate | ≤20ppm |
Arsenic | ≤10ppm |
Nā Metala Kaumaha | ≤10ppm |
Hoʻāʻo | ≥99.0% |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Mea Hana Lapaʻau Hoʻoikaika (API) |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o Revaprazan Hydrochloride (CAS: 178307-42-1) me ke kūlana kiʻekiʻe.Hoʻemi ʻo Revaprazan Hydrochloride i ka ʻōlelo COX-2 a loaʻa i nā hana anti-inflammatory koʻikoʻi i ka maʻi H. pylori.ʻO Revaprazan Hydrochloride i ka mālama ʻana i ka maʻi maʻi duodenal, ʻeha ʻōpū a me ka gastritis.
ʻO Revaprazan Hydrochloride (kahi i ʻike ʻia ʻo ka reversible proton pump inhibitors, potassium competitive acid blockers, p-CABs) he hanauna hou o ka reversible proton pump inhibitors a ʻo ia wale nō ka mea kūʻai aku i nā mea pāʻani pākīpika hoʻokūkū hoʻokūkū pāpaʻi a i ʻole nā mea kūʻē i ka pauma waikawa i ka honua.Hoʻomohala ʻia e ka hui ʻo Yuhan Hema a me nā kuleana waiwai naʻauao, ua loaʻa iā GLAxoSmithKline nā laikini hoʻomohala honua a kūʻai aku no ka lāʻau ma waho o South Korea a me North Korea.Ua ʻae ʻia ka lāʻau lapaʻau e ka South Korea FDA i ka makahiki 2007 e mālama i ka ʻeha duodenal a me ka gastritis.